For some families, this is a daily reality due to rare genetic disorders. One such condition is Sanfilippo syndrome, which creates significant hurdles for affected children and their families.
The biotechnology company, Ultragenyx, has reported a successful fourth quarter and full year 2024 financial results ...
GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its ...
Reports Q4 revenue $164.88M, consensus $158.71M. “We have created a next-generation rare disease company on a pathway to profitability with ...
Pharmaceutical announced new data demonstrating treatment with UX111 AAV gene therapy led to a statistically significant ...
WWMT Grand Rapids/Lansing on MSN14d
Annual Kozminski Memorial game honors fallen officer while aiding family in needThe Grand Rapids Police Department will face the Kentwood Police Department in just one of the matchups scheduled for the ...
Emil Kakkis; President, Chief Executive Officer, Director; Ultragenyx Pharmaceutical Inc Erik Harris; Executive Vice President, Chief Commercial Officer; Ultragenyx Pharmaceutical Inc Howard Horn; ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback